Related Experiment Videos
Analgesia for paediatric tonsillectomy and adenoidectomy with intramuscular clonidine
Katherine O Freeman1, Neil Roy Connelly, Donald Schwartz
1Department of Anesthesiology, Baystate Medical Center, Springfield, MA 01199, USA.
Insights
Intramuscular clonidine did not reduce pain in children after tonsillectomy and adenoidectomy. This study found no significant differences in pain scores or analgesic needs between clonidine and saline groups.
Area of Science:
- Pediatric Anesthesiology
- Pain Management
- Pharmacology
Background:
- Post-tonsillectomy and adenoidectomy (T&A) pain is a significant concern in pediatric patients.
- Clonidine, an alpha2 agonist, is known for its analgesic properties.
- Investigating novel pain management strategies is crucial for pediatric surgical care.
Purpose of the Study:
- To evaluate the efficacy of intramuscular (I.M.) clonidine in reducing pain.
- To assess the impact of I.M. clonidine on perioperative analgesic requirements.
- To determine if I.M. clonidine improves pain control in children undergoing T&A.
Main Methods:
- A randomized controlled trial involving 39 pediatric patients undergoing elective T&A.
- Standardized anesthesia induction with fentanyl and rectal acetaminophen.
- Randomized administration of either I.M. clonidine (2 microg x kg(-1)) or normal saline.
Main Results:
- No statistically significant differences were observed in pain scores between the clonidine and saline groups.
- Analgesic consumption in the post-anesthesia care unit and at home did not differ significantly.
- Hemodynamic parameters remained comparable between the two treatment groups.
Conclusions:
- Intramuscular clonidine at a dose of 2 microg x kg(-1) is not recommended as an adjunct for pain management.
- Current evidence does not support the routine use of I.M. clonidine for T&A pain in children.
- Further research may explore alternative dosages or routes of administration for clonidine in pediatric pain.
Background:
After undergoing tonsillectomy and adenoidectomy (T&A), children may experience significant pain. Clonidine, an alpha2 agonist, exhibits significant analgesic properties. The current investigation sought to determine whether intramuscular (I.M.) clonidine would decrease pain in paediatric patients undergoing T&A.
Methods:
Thirty-nine children undergoing elective T&A were studied. Following inhalational anaesthetic induction, fentanyl (2 microg x kg(-1)) was given intravenously, acetaminophen (paracetamol) (30 mg.kg-1) was given rectally and the children then randomly received an i.m. injection of either normal saline or clonidine (2 microg x kg(-1)). Perioperative analgesic requirements in the postanaesthesia care unit and at home following hospital discharge were evaluated.
Results:
There were no significant demographic, analgesic consumption, haemodynamic or pain score differences between the groups.
Conclusions:
We do not recommend adding i.m. clonidine (2 microg x kg(-1)) to the analgesic regimen of children undergoing tonsillectomy and adenoidectomy.